Jun 14, 2017 06:01 am UTC| Business
June 14, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment...
Motif Bio to Present at BIO International Convention
Jun 14, 2017 06:00 am UTC| Business
NEW YORK, June 14, 2017 -- Motif Bio plc (NASDAQ:MTFB) (AIM:MTFB.LN), a clinical stage biopharmaceutical company specializing in developing novel antibiotics, today announced that the Company will present at BIO 2017...
Jun 14, 2017 05:56 am UTC| Business
Reference is made to the announcement made on 29 May 2017 by Statoil ASA (OSE:STL, NYSE:STO) regarding the dividend issue for the fourth quarter 2016 ("the Dividend Issue"). The subscription price shall, in accordance...
CGG: Launches JumpStart Regional Geoscience Programs to Support Prospectivity Evaluation
Jun 14, 2017 05:32 am UTC| Business
CGG Launches JumpStart Regional Geoscience Programs to Support Prospectivity Evaluation Paris, France - June 14, 2017 CGG announced today at the 2017 EAGE Conference Exhibition the launch of JumpStart(TM)...
Jun 14, 2017 05:16 am UTC| Business
Basel, Switzerland, June 14, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Basilea Pharmaceutica International Ltd. (Basilea) has entered into a distribution and license agreement with Avir Pharma Inc....
Jun 14, 2017 05:01 am UTC| Business
GHENT, Belgium, 14 June 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] announces that it will present additional data from the two Phase IIb studies in rheumatoid arthritis (RA) with its anti-IL-6R Nanobody®,...
Diet Doc’s New Low-Dose Naltrexone Helps Dieters Fight Off Sugar Addiction
Jun 14, 2017 05:00 am UTC| Business
Charleston, WV, June 14, 2017 -- The prevalence of sugar in the American diet is astounding. Its link to obesity, diabetes, inflammatory conditions is enough to make one want to quit consuming sugar for good. The...